The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Open accessAbstract
The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [107]
In the citing paper
“Insulin resistance in skeletal muscle is manifested by decreased insulin-stimulated glucose uptake and results from impaired insulin signaling and multiple post-receptor intracellular defects including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The ability of insulin to activate insulin receptor and IRS-1 tyrosine phosphorylation in muscle in obese nondiabetic subjects is modestly reduced; whereas in type 2 diabetics insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation are severely impaired [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“In insulin-resistant obese nondiabetic subjects, in the NGT insulin resistant offspring of two diabetic parents, and in type 2 diabetic subjects, a substantial decrease in insulin receptor tyrosine phosphorylation has been demonstrated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The decrease in insulin-stimulated association of the p85 regulatory subunit of PI3K with IRS-1 is closely correlated with the reduction in insulin-stimulated muscle glycogen synthase activity and in vivo insulin-stimulated glucose disposal [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Intact stimulation of the MAPK pathway by insulin in the presence of insulin resistance in the PI3K pathway may play an important role in the development of atherosclerosis [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Under basal conditions, total glycogen synthase activity in type 2 diabetic subjects is reduced, and the ability of insulin to activate glycogen synthase is severely impaired [7, 215–217].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Self-citationMeasurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Effect of physical exercise on sensitivity and responsiveness to insulin in humans
Mikines, K. J., Sonne, B., Farrell, P. A., Tronier, B., & Galbo, H. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e248 · Cited by 538
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Ren, J., Semenkovich, C. F., Gulve, E. A., Gao, J. H., & Holloszy, J. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36636-x · Cited by 416
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Nyomba, 1990, Am J Physiol, 258, E964
- Hayashi, 1997, Am J Physiol, 273, E1039
- Koval, 1998, Am J Physiol, 274, E304
- O’Doherty, 1994, Am J Physiol, 266, E171
- Mikines, 1988, Am J Physiol, 254, E248
- Goodyear, 1995, Am J Physiol, 268, E987
- Zorzano, 1986, Am J Physiol, 251, E664
- Kochan, 1979, Am J Physiol, 236, E660
Cited by
Sorted by citations
Items 701–800 of 997
Cardiovascular correlates of insulin resistance in normotensive and hypertensive African Americans
Kidambi, S., Kotchen, J. M., Krishnaswami, S., Grim, C. E., & Kotchen, T. A. (2010) · Metabolism · doi:10.1016/j.metabol.2010.07.036 · Cited by 13
Insulin Resistance and Thrombogenesis: Recent Insights and Therapeutic Implications
Ba'albaki, H. A., & Bell, D. S. H. (2007) · Endocrine Practice · doi:10.4158/ep.13.6.679 · Cited by 13
Bishop, E. A., Lightfoot, S. A., Thavathiru, E., & Benbrook, D. M. (2014) · Cancer Investigation · doi:10.3109/07357907.2013.877479 · Cited by 12
Sgarra, L., Addabbo, F., Potenza, M. A., & Montagnani, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00038.2012 · Cited by 13
Premilovac, D., Attrill, E., Rattigan, S., Richards, S. M., Kim, J., & Keske, M. A. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy225 · Cited by 13
Ortmeyer, H. K., Sajan, M. P., Miura, A., Kanoh, Y., Rivas, J., Li, Y., Standaert, M. L., Ryan, A. S., Bodkin, N. L., Farese, R. V., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3234 · Cited by 13
Sharma, N., Bhat, A. D., Kassa, A. D., Xiao, Y., Arias, E. B., & Cartee, G. D. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00372.2011 · Cited by 13
McCarty, M. F. (2002) · Medical Hypotheses · doi:10.1054/mehy.2001.1455 · Cited by 13
Ayala, J. E., Boustead, J. N., Chapman, S. C., Svitek, C., Oeser, J. K., Robey, R. B., & O'Brien, R. M. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0330263 · Cited by 13
Lee, W., Ham, J., Kwon, H. C., Yoon, G., Bae, G., Kim, Y. K., & Kim, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2227 · Cited by 12
Roberts, A., Gohil, J., Hudson, L., Connolly, K., Warburton, P., Suman, R., O’Toole, P. J., O'Regan, D. J., Turner, N. A., Riches‐Suman, K., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/409432 · Cited by 12
5,7-Dihydroxy-6-geranylflavanone improves insulin sensitivity through PPARα/γ dual activation
Lee, W., Yoon, G., KIM, M. C., Kwon, H. C., Bae, G., Kim, Y. K., & Kim, S. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2531 · Cited by 12
Bronsveld, H. K., Bruin, M. L. D., Wesseling, J., Sanders, J., Hofland, I., Jensen, V., Bazelier, M. T., ter Braak, B., de Boer, A., Vestergaard, P., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4072-8 · Cited by 12
Bilberries and blueberries as potential modulators of type 2 diabetes and associated diseases
Habtemariam, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102922-0.00007-9 · Cited by 12
Pathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., John‐Kalarickal, J., & Fonseca, V. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_13 · Cited by 13
Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19
Mayoral, L. P.-C., Matias‐Cervantes, C. A., Pérez‐Campos, E., Díaz, C. R., Barrios, L. Á. L., Pina-Canseco, M. D. S., Cruz, M. M., Mayoral, E. P., Solórzano-Mata, C. J., Canales, F. J. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158277 · Cited by 14
Hsiao, M., Lu, P., Huang, H.-N., Lo, W.-C., Ho, W.-Y., Lai, T., Chiang, H.-T., & Tseng, C.-J. (2008) · Hypertension Research · doi:10.1291/hypres.31.1209 · Cited by 12
Insulin Action and Endothelial Function
Mather, K. J., Baron, A., & Quon, M. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_7 · Cited by 12
Efficacy of Sirolimus-Eluting Stents in Diabetics With Complex Coronary Lesions
Berenguer, A., Mainar, V., Bordes, P., Valencia, J., & Gómez, S. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60119-9 · Cited by 12
Jazet, I. M., Ouwens, D. M., Schaart, G., Pijl, H., KEIZER, H. A., Maassen, J. A., & Meinders, A. E. (2005) · Metabolism · doi:10.1016/j.metabol.2005.06.017 · Cited by 12
Shashkin, P. N., Wasner, H. K., Ortmeyer, H. K., & HANSEN, B. C. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.218 · Cited by 12
Wadley, G. D., Bruce, C. R., Konstantopoulos, N., Macaulay, S. L., Howlett, K. F., Hawley, J. A., & Cameron‐Smith, D. (2004) · Diabetologia · doi:10.1007/s00125-003-1322-2 · Cited by 12
Effects of insulin and free fatty acids on matrix metalloproteinases
Boden, G. H., & Song, W. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0041-y · Cited by 12
Wu, C., Lin, C.-C., Hsieh, F.-C., Wu, T.-Y., & Fang, A.-H. (2023) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2023/1011591 · Cited by 11
Cersósimo, E., Xu, X., Terasawa, T., & Dong, L. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05707-w · Cited by 12
Glyoxalase I is a novel target for the prevention of metabolic derangement
Miranda, E. R., & Haus, J. M. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108524 · Cited by 11
The Impact of Pharmacotherapy of Type 2 Diabetes Mellitus on IL-1β, IL-6 and IL-10 Secretion
Borowska, M., Dworacka, M., Wesołowska, A., Winiarska, H., Krzyżagórska, E., & Dworacki, G. (2016) · Pharmacology · doi:10.1159/000443897 · Cited by 11
Yunn, N.-O., Kim, J. J., Kim, Y., Leibiger, I. B., Berggren, P., & Ryu, S. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.005 · Cited by 11
Nostell, K. E. A., Lindåse, S. S., Edberg, H., & Bröjer, J. T. (2019) · Equine Veterinary Journal · doi:10.1111/evj.13110 · Cited by 12
González‐Hedström, D., Guerra-Menéndez, L., Tejera‐Muñoz, A., Amor, S., de la Fuente‐Fernández, M., Martín-Carro, B., Arriazu, R., García-Villalón, Á. L., & Granado, M. (2020) · Nutrients · doi:10.3390/nu12020549 · Cited by 13
Li, Y., Ma, Q., Li, P., Wang, J., Wang, M., Fan, Y., Wang, T., Wang, C., Wang, T., & Zhao, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29658 · Cited by 13
Mechanisms Underlying Insulin Resistance in Human Pregnancy and Gestational Diabetes Mellitus
McCurdy, C. E., & Friedman, J. E. (2010) · Springer eBooks · doi:10.1007/978-1-84882-120-0_9 · Cited by 11
Linking diabetes and atherosclerosis
Candido, R., Bernardi, S., & Allen, T. J. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.46 · Cited by 11
Amino acids influence the glucose uptake through GLUT4 in CHO-K1 cells under high glucose conditions
Selvi, R., Angayarkanni, N., Asma, B., Seethalakshmi, T. S., & Srinivasan, V. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0527-1 · Cited by 10
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., & Chaiken, R. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_34 · Cited by 12
The 6th Annual World Congress on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2009) · Diabetes Care · doi:10.2337/dc09-zb09 · Cited by 11
O’Brien, K., Sekimoto, H., Boney, C. M., & Malee, M. P. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802213073 · Cited by 11
Towards an Insulin Resistant Adipose Model on a Chip
Tanataweethum, N., Zhong, F., Trang, A., Lee, C., Cohen, R., & Bhushan, A. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00636-x · Cited by 12
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 11
Self-citationSchwanstecher, C., & Schwanstecher, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_1 · Cited by 11
Chen, S., Yan, W., Huang, J., Ge, D., Yao, Z. J., & Gu, D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01490.x · Cited by 12
White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues
Abbasi, K., Zarezadeh, R., Valizadeh, A., Mehdizadeh, A., Hamishehkar, H., Nouri, M., & Darabi, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.116012 · Cited by 12
Independent association of thigh muscle fat density with vascular events in Korean adults
Choe, H. J., Chang, W., Blüher, M., Heymsfield, S. B., & Lim, S. H. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02138-w · Cited by 10
Luo, G., Hong, T., Yu, L., & Ren, Z. (2023) · Cells · doi:10.3390/cells12030369 · Cited by 10
Gaster, M. (2018) · Apmis · doi:10.1111/apm.12908 · Cited by 12
Increased Endothelin-1-Mediated Vasoconstrictor Tone in Human Obesity: Effects of Gut Hormones
Schinzari, F., Tesauro, M., & Cardillo, C. (2018) · Physiological Research · doi:10.33549/physiolres.933821 · Cited by 10
Publisher, B. S. P. B. S. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106778521599 · Cited by 9
Advances in the development of AMPK-activating compounds
Sriwijitkamol, A., & Musi, N. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.10.1167 · Cited by 10
Coletta, D. K., Campbell, L. E., Weil, J., Kaplan, B. E., Clarkson, M., Finlayson, J., Mandarino, L. J., & Chakkera, H. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160327 · Cited by 10
Self-citationApproaches to identify kinase dependencies in cancer signalling networks
Dermit, M., Dokal, A. D., & Cutillas, P. R. (2017) · FEBS Letters · doi:10.1002/1873-3468.12748 · Cited by 10
Role of protein kinase C in diabetic complications
King, G. L., & Daş-Evcimen, N. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.74 · Cited by 9
Pathophysiology of type II diabetes mellitus
Pierre-Jerome, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13328-2.00003-9 · Cited by 11
Specificity of insulin signalling in human skeletal muscle as revealed by small interfering RNA
Krook, A., & Zierath, J. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1330-y · Cited by 10
Jafarnezhad, F., Nazarzadeh, A., Bazavar, H., Keramat, S., Ryszkiel, I., & Stanek, A. (2025) · Nutrients · doi:10.3390/nu17162656 · Cited by 15
Васильевна, М. Г., Shilovsky, G. A., & Khokhlov, A. N. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921100151 · Cited by 9
Neuronal insulin signaling and resistance: a balancing act of kinases and phosphatases
Sharma, M., Yadav, Y., & Dey, C. S. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0151 · Cited by 11
Elevated fasting serum insulin level predicts future development of hypertension
Park, S. K., Jung, J. Y., Choi, W. J., Kim, Y. H., Kim, H. S., Ham, W. T., Shin, H., & Ryoo, J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.01.087 · Cited by 9
Cheng, C., Nakamura, A., Minamimoto, R., Shinoda, K., Tateishi, U., Goto, A., Kadowaki, T., Terauchi, Y., & Inoue, T. (2011) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0522-y · Cited by 9
Hepatic deficiency of Poldip2 in type 2 diabetes modulates lipid and glucose homeostasis
Jiang, Z., Zhou, J., Li, T., Tian, M., Lü, J., Jia, Y., Wan, G., & Chen, K. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153948 · Cited by 9
Schinzari, F., & Cardillo, C. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0651 · Cited by 9
Shu, Y. L., Yang, X., Wei, L., Wen, C., Luo, H., Qin, T., Ma, L., Liu, Y., Wang, B., Liu, C., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117049 · Cited by 9
Hayata, K., Sakano, K.-I., & Nishinaka, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08148fp · Cited by 9
Li, X., Li, X., Wang, Y., Xu, Y., Wang, Y., Hao, R., & Ma, X. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0662-8 · Cited by 9
Golovchenko, I., Yang, C., Goalstone, M. L., & Draznin, B. (2003) · Metabolism · doi:10.1053/meta.2003.50042 · Cited by 9
Mechanisms of Insulin Signal Transduction
Garvey, W. T. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0301 · Cited by 10
The Syndrome of Insulin Resistance and Its Links to Atherosclerosis
Bonadonna, R. C. (2003) · doi:10.1002/0470862092.d1009 · Cited by 9
Inhibition of MEK1 signaling pathway in the liver ameliorates insulin resistance
Ueyama, A., Ban, N., Fukazawa, M., Hirayama, T., Takeda, M., Yata, T., Muramatsu, H., Hoshino, M., Yamamoto, M., Matsuo, M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8264830 · Cited by 7
Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
HE, Z. (2003) · European Heart Journal Supplements · doi:10.1016/s1520-765x(03)90041-1 · Cited by 8
Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome
Wang, C. C. L., Lu, L., Leitner, J. W., Sarraf, M., Gianani, R., Draznin, B., Greyson, C. R., Reusch, J. E. B., & Schwartz, G. G. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.02.009 · Cited by 8
Eldor, R., Norton, L., Fourcaudot, M. J., Galindo, C., DeFronzo, R., & Abdul-Ghani, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188208 · Cited by 8
Self-citationPark, J., Jung, T. W., Chung, Y. H., Park, E. S., & Jeong, J. H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.019 · Cited by 8
Insulin-mediated muscle microvascular perfusion and its phenotypic predictors in humans
Love, K. M., Jahn, L. A., Hartline, L. M., Patrie, J. T., Barrett, E. J., & Liu, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-90935-8 · Cited by 8
Kesharwani, D., Kumar, A., Poojary, M., Scaria, V., & Datta, M. (2021) · Bioscience Reports · doi:10.1042/bsr20210495 · Cited by 9
Young, B. E., Padilla, J., Finsen, S. H., Fadel, P. J., & Mortensen, S. P. (2022) · Endocrinology · doi:10.1210/endocr/bqac008 · Cited by 8
Ijuin, T., & Takenawa, T. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.031 · Cited by 7
Skalska, A., Gąsowski, J., & Grodzicki, T. K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.026 · Cited by 8
Zhang, X., Højlund, K., Luo, M., Meyer, C., Geetha, T., & Yi, Z. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.05.009 · Cited by 8
Korsheninnikova, E., Seppälä‐Lindroos, A., Vehkavaara, S., Goto, T., & Virkamäki, A. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.272 · Cited by 8
Coletta, D. K., Fernandez, M., Cersósimo, E., Gastaldelli, A., Musi, N., & DeFronzo, R. A. (2014) · Diabetic Medicine · doi:10.1111/dme.12664 · Cited by 8
Self-citationRole of Protocatechuic Acid in Obesity-Related Pathologies
D’Archivio, M., Scazzocchio, B., Giovannini, C., & Masella, R. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00015-3 · Cited by 10
Insulin Resistance and Endothelial Dysfunction: Macro and Microangiopathy
Arce‐Esquivel, A. A., Aaron, K. E., Catherine, R., & Laughli, M. H. (2013) · InTech eBooks · doi:10.5772/56475 · Cited by 9
Isenović, E. R., Frétaud, M., Dobutović, B., Sudar-Milovanovic, E. M., Smiljanić, K., Zarić, B. L., Trpković, A., & Marché, P. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.01.010 · Cited by 8
Insulin-nonspecific reduction in skeletal muscle glucose transport in high-fat-fed rats
Koshinaka, K., Oshida, Y., Han, Y.-Q., Kubota, M., Viana, A. Y. I., Nagasaki, M., & Sato, Y. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.026 · Cited by 8
Kumar, N., & Dey, C. S. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000026054.60072.48 · Cited by 8
Endothelial Dysfunction and Insulin Resistance
Sriraman, R., & Tooke, J. E. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/1540419042441867 · Cited by 9
Cardiovascular fitness and type 2 diabetes
Mullooly, C. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0109-z · Cited by 8
Novel Aspects on Insulin Resistance
Anderwald, C. H. (2009) · The Endocrinologist · doi:10.1097/ten.0b013e3181c0479d · Cited by 8
Mechanisms of insulin signal transduction
Langlais, P. R., Mandarino, L. J., & Garvey, W. T. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch12 · Cited by 8
Self-citationSnogdal, L. S., Wod, M., Grarup, N., Vestmar, M. A., Sparsø, T., Jørgensen, T., Lauritzen, T., Beck‐Nielsen, H., Henriksen, J. E., Pedersen, O. B., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2377-0 · Cited by 7
Saleh, B. O. M., Majeed, M. J., & Oreaby, G. M. (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-13932835 · Cited by 7
Regulation of Intermediatory Metabolism During Fasting and Feeding
DeFronzo, R. A., & Ferrannini, E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00036-8 · Cited by 7
Self-citationLa cintura hipertrigliceridémica
Ascaso, J. F. (2005) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(05)73357-x · Cited by 8
Guo, H., Lv, H., Tang, W., Chi, J., Liu, L., Xu, F., Ji, Z., Zhai, X., & Peng, F. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6406-0 · Cited by 7
Phosphorylation of myocardial eNOS is altered in patients suffering from type 2 diabetes
Streit, U., Reuter, H., Bloch, W., Wahlers, T., Schwinger, R. H. G., & Brixius, K. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00011.2011 · Cited by 7
Pathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., & Fonseca, V. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-20797-1_13-1 · Cited by 7
Metformin Inhibits N-Methyl-N-Nitrosourea Induced Gastric Tumorigenesis in db/db Mice
Zhuang, S., Jian, Y., & Sun, Y. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-100118 · Cited by 7
Differential proteome analysis of diabetes mellitus type 2 and its pathophysiological complications
Sohail, W., Majeed, F., & Afroz, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.06.009 · Cited by 7
Pan, M., Sun, Q., Li, C., Tai, R., Shi, X., & Sun, C. (2022) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0558 · Cited by 7
Pathogenesis of Type 2 Diabetes Mellitus
Kalin, M. F., Goncalves, M., John‐Kalarickal, J., & Fonseca, V. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_13-2 · Cited by 7
Wu, Y., Ouyang, J.-P., Zhou, Y., Wu, K., De-hai, Z., & Wen, C.-Y. (2004) · PubMed · Cited by 7
Metadata
- Authors
- Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Harvard University (US)
- Tulane University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Mandarino, Lawrence J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377440
- OpenAlex
- W2120852510
- Cited by
- 1,139
- References
- 48
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 19 · 2023: 27 · 2022: 35 · 2021: 45 · 2020: 33 · 2019: 35 · 2018: 24 · 2017: 37 · 2016: 52 · 2015: 54 · 2014: 53 · 2013: 57 · 2012: 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, DK02526, R01DK047936, R01DK033201, R01DK024092, R01-DK-47936)
- National Center for Research Resources (M01RR001346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, skeletal muscle, type 2 diabetes, PI3K signaling, MAPK signaling, insulin receptor, IRS-1, p85 regulatory subunit, physical activity, glucose uptake, obesity, euglycemic clamp, insulin signaling
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Phosphoproteins, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
